Therapeutic apheresis
Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
... In our study cohorts spuriously elevated intrathecal Ig fractions were commonly found after therapeutic apher- esis only in those cases for which the time interval after therapeutic intervention to CSF ...
6
THERAPEUTIC APHERESIS
... these apheresis services become commonplace, some physicians can expect a back-and- forth process of rate negotiation with commercial insurers that agree to cover therapeutic apheresis procedures for ...
32
Therapeutic apheresis in tropical medicine
... Ebola, Marburg hemorrhagic fever: In recent years, there have been reports of severe course of a number of hemorrhagic fevers caused by Ebola and Marburg viruses, accompanied by intoxication and severe shock with ...
6
Therapeutic apheresis in autoimmune diseases
... treatment. Therapeutic apheresis in combination with immunosuppressive therapies has led to a steady increase in survival rates over the last 35 ...that therapeutic apheresis can be a ...
11
Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartments during sepsis, studies in a rat model
... that therapeutic apheresis by using a hemoadsorption (HA) device composed of these beads could alter immune-mediator concentra- tions in the plasma, protect against organ injury, and improve survival ...
13
Spectra Optia<sup>®</sup> Apheresis System: current insights into clinical risks and benefits
... various therapeutic apheresis procedures, cell collection and processing ...specific apheresis devices in therapeutic ...this Apheresis System in therapeutic apheresis, ...
8
Therapeutic Communities
... Covington SS, Bloom BE. Gender-responsive treatment and services in correctional settings. In: Leeder E, ed. Inside and Out: Women, Prison, and Therapy. New York, NY: Haworth Press; 2006:9 – 24. De Leon G, Wexler H. The ...
16
Therapeutic Modalities.pdf
... of therapeutic techniques in the treatment and rehabilitation of ...of therapeutic mo- ...that therapeutic modalities are useful tools in injury ...
431
Therapeutic Modalities
... Cryotherapy is usually applied for 20 to 30 minutes for maximum cooling of both superficial and deep tissues. Barriers used between the ice application and skin can affect heat abstraction. Research has shown that a dry ...
28
Lipoprotein turnover and possible remnant accumulation in preeclampsia: insights from the Freiburg Preeclampsia H.E.L.P.-apheresis study
... Heparin is administered before and during apheresis. Heparin liberates lipoprotein lipase (LPL), hepatic lipase (HL) and endothelial lipase from the liver and other tis- sues [41], and the liberated lipases ...
11
Therapeutic emails
... Success in this phase of treatment is promoted by family and friends of the client altering daily routines to make it difficult for the client to continue drug use.. Success is also prom[r] ...
18
Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by In Vivo High Resolution CMR a comparative analysis
... lipid apheresis therapy in addition to lowering serum lipid levels also has an influence on development and progression of atherosclerotic ...lipid apheresis (LA) on the composition of atherosclerotic ...
8
Therapeutic Exercise
... ◦ Isometric Contraction: static; produced when muscle tension is created without a change in muscle length. Isometrics performed at one angle results in[r] ...
84
Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease
... Studies of immunopathogenesis behind IBD have recently identified the innate immune system as a major player in mucosal inflammation [40]. The activated gran- ulocytes and macrophages are important sources of pro- ...
10
Evaluation of vascular quality of life questionnaire in dialysis patients with peripheral arterial disease treated by low-density lipoprotein apheresis
... long-term therapeutic effects of LDL-A against PAD in dialysis patients ABI and SPP were also continuously monitored as repre- sentative tests for peripheral ...long-term therapeutic effects of LDL-A ...
9
Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
... is to avoid adverse side effects of drugs. Ideally, physi- cians and in particular, patients hope treatment to be safe and effective. However, the reality of clinical prac- tice would show that any given ...
9
An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn’s disease
... No device-related serious adverse event or unexpected ad- verse event was observed in either group. Adverse events were consistent with those generally observed during extracorporeal procedures including transient ...
8
therapeutic relationships
... the therapeutic relationship include: active listening, trust, respect, genuineness, empathy, and responding to client ...the therapeutic relationship (orientation, working, resolution), and discovered that ...
62
Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study
... The observation time interval was from baseline (within 2 weeks before the 1st GMA session) to the final assess- ment time (within 1 month after the 10th or 11th GMA sessions in patients with UC and the 10th session in ...
15
Lipoprotein glomerulopathy treated with LDL apheresis (Heparin induced Extracorporeal Lipoprotein Precipitation system): a case report
... of therapeutic protocol with statins, the patient was admitted for nephrotic syndrome, renal failure and ...- apheresis (HELP- apheresis) was started to maintain angiotensin converting enzyme ...
6